ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 734626 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 734626; 2) Community: the network communities that were significantly associated with the response to NSC 734626; 3) Molecule: the relationships between components within communities and NSC 734626; 4) MDR: the compounds that were significantly associated with the NSC 734626.

NSC Compound Enrichment Correlation
NSC 702734 Null 0.011544784012433 0.16579609
NSC 717065 Null 0.011544784012433 0.17373715
NSC 727987 NSC 708783 incorporated in micelles, 0.20% (w/w) of drug 0.011544784012433 0.025969083
NSC 734231 2[4'aminobiphenyl]5,6dichlorobenzimidazole 0.011544784012433 0.16703415
NSC 746687 (2E)-3-(2-phenyl-1H-indol-3-yl)-2-(phenylsulfonyl)acrylonitrile 0.0115447840124334 0.2759126
NSC 756134 GSK1023156A 0.0115447840124334 0.17157835
NSC 125347 Null 0.0141370771633662 0.094976352
NSC 128571 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) 0.0141370771633662 0.32168121
NSC 143925 Pekilocerin A 0.0141370771633662 0.090645129
NSC 169774 Bromocriptine methanesulfonate 0.0141370771633662 0.23651672
Total:110  Current:42    [First] [Prev] [Next] [Last]